Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...

Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the ...

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

How lawyers for the nurse currently serving 15 life sentences for the murder of seven babies will try to overturn her ...

The United Nations Children’s Fund (UNICEF) and Tejarat Bank have started a campaign titled ‘Disability is part of me, not ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

Nebraska Lutheran built a 26-14 halftime lead and then held off a McCool Junction surge down the stretch, picking up a 43-40 win behind a combined 24 points from Rebecca ...

Not yet, and not quite, even as President Trump’s agenda instead puts the news spotlight on transgender issues. Though the Supreme Court’s historic 2015 Obergefell v. Hodges decision to legalize gay ...

This will involve observing their daily routines and energy consumption habits to identify emerging trends and co-design new energy tools and practices. By observing households over time, the project ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...